Edgewell Personal Care Company (EPC) P/E Ratio History
ExpensiveTrading at 43.6x vs 5Y avg 21.5x · 100th percentile · Material premium to history · Data 2000–2025
Loading P/E history...
P/E Ratio Analysis
As of June 22, 2026, Edgewell Personal Care Company (EPC) trades at a price-to-earnings ratio of 43.6x, with a stock price of $23.11 and trailing twelve-month earnings per share of $-1.67.
The current P/E is 102% above its 5-year average of 21.5x. Over the past five years, EPC's P/E has ranged from a low of 16.1x to a high of 40.2x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Consumer Defensive sector median P/E of 18.8x, EPC trades at a 132% premium to its sector peers. The sector includes 151 companies with P/E ratios ranging from 0.0x to 193.7x.
Relative to the broader market, EPC commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our EPC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
EPC Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
EPC P/E vs Peers
Personal Care and Beauty Products peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $23B | 31.7 | - | +27% | |
| $2B | 21.8 | 1.68 | -6% | |
| $1B | 6.5Lowest | 0.17Best | +538%Best | |
| $351B | 23.1 | 4.13 | +8% | |
| $128B | 22.3 | 16.32 | -11% | |
| $34B | 16.9 | - | -20% | |
| $72B | 34.0 | - | -25% | |
| $20B | 26.7 | 2.21 | -4% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
EPC Historical P/E Data (2000–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | - | $20.36 | $0.51 | 40.2x | +14% |
| FY2025 Q3 | Jun 30 2025 | $23.41 | $1.35 | 17.4x | -51% |
| FY2025 Q2 | Mar 31 2025 | $31.21 | $1.72 | 18.2x | -49% |
| FY2025 Q1 | - | $33.60 | $1.84 | 18.3x | -48% |
| FY2024 Q4 | Sep 30 2024 | $36.34 | $1.98 | 18.4x | -48% |
| FY2024 Q3 | Jun 30 2024 | $40.19 | $2.37 | 17.0x | -52% |
| FY2024 Q2 | Mar 31 2024 | $38.64 | $2.40 | 16.1x | -54% |
| FY2024 Q1 | Dec 31 2023 | $36.63 | $2.04 | 17.9x | -49% |
| FY2023 Q4 | Sep 30 2023 | $36.96 | $2.18 | 17.0x | -52% |
| FY2023 Q3 | Jun 30 2023 | $41.31 | $2.25 | 18.4x | -48% |
| FY2023 Q2 | Mar 31 2023 | $42.42 | $1.81 | 23.4x | -34% |
| FY2023 Q1 | Dec 31 2022 | $38.54 | $1.87 | 20.6x | -42% |
| FY2022 Q4 | Sep 30 2022 | $37.40 | $1.84 | 20.3x | -42% |
| FY2022 Q3 | - | $34.52 | $2.00 | 17.3x | -51% |
| FY2022 Q2 | - | $36.67 | $2.17 | 16.9x | -52% |
| FY2022 Q1 | Dec 31 2021 | $45.71 | $2.00 | 22.9x | -35% |
| FY2021 Q4 | - | $36.30 | $2.12 | 17.1x | -52% |
| FY2021 Q3 | Jun 30 2021 | $43.90 | $1.70 | 25.8x | -27% |
| FY2021 Q2 | Mar 31 2021 | $39.60 | $1.05 | 37.7x | +7% |
| FY2021 Q1 | - | $34.58 | $1.15 | 30.1x | -15% |
| FY2020 Q4 | Sep 30 2020 | $27.88 | $1.24 | 22.5x | -36% |
| FY2020 Q3 | - | $31.16 | $1.61 | 19.4x | -45% |
| FY2019 Q2 | Mar 31 2019 | $43.89 | $1.46 | 30.0x | -15% |
| FY2019 Q1 | Dec 31 2018 | $37.35 | $1.77 | 21.1x | -40% |
| FY2018 Q4 | Sep 30 2018 | $46.23 | $1.90 | 24.3x | -31% |
| FY2017 Q4 | Sep 30 2017 | $72.77 | $0.05 | 1455.4x | +4020% |
| FY2017 Q3 | Jun 30 2017 | $76.02 | $3.55 | 21.4x | -39% |
| FY2017 Q2 | Mar 31 2017 | $73.14 | $3.21 | 22.8x | -35% |
| FY2017 Q1 | Dec 31 2016 | $72.99 | $3.17 | 23.0x | -35% |
| FY2016 Q4 | Sep 30 2016 | $79.52 | $2.98 | 26.7x | -24% |
| FY2015 Q3 | - | $97.55 | $0.46 | 212.1x | +500% |
| FY2015 Q2 | - | $102.37 | $2.66 | 38.5x | +9% |
| FY2015 Q1 | Dec 31 2014 | $95.33 | $5.65 | 16.9x | -52% |
| FY2014 Q4 | - | $91.37 | $5.67 | 16.1x | -54% |
| FY2014 Q3 | Jun 30 2014 | $90.49 | $5.97 | 15.2x | -57% |
| FY2014 Q2 | Mar 31 2014 | $74.70 | $6.32 | 11.8x | -67% |
| FY2014 Q1 | - | $80.26 | $6.10 | 13.2x | -63% |
| FY2013 Q4 | Sep 30 2013 | $67.59 | $6.46 | 10.5x | -70% |
| FY2013 Q3 | Jun 30 2013 | $74.53 | $6.64 | 11.2x | -68% |
| FY2013 Q2 | Mar 31 2013 | $73.95 | $6.32 | 11.7x | -67% |
| FY2013 Q1 | Dec 31 2012 | $59.31 | $6.14 | 9.7x | -73% |
| FY2012 Q4 | Sep 30 2012 | $55.33 | $6.22 | 8.9x | -75% |
| FY2012 Q3 | Jun 30 2012 | $55.80 | $5.05 | 11.0x | -69% |
| FY2012 Q2 | Mar 31 2012 | $55.01 | $4.93 | 11.2x | -68% |
| FY2012 Q1 | Dec 31 2011 | $57.45 | $4.31 | 13.3x | -62% |
| FY2011 Q4 | Sep 30 2011 | $49.27 | $3.71 | 13.3x | -62% |
| FY2011 Q3 | - | $53.66 | $4.24 | 12.7x | -64% |
| FY2011 Q2 | - | $52.77 | $4.77 | 11.1x | -69% |
| FY2011 Q1 | Dec 31 2010 | $54.06 | $5.47 | 9.9x | -72% |
| FY2010 Q4 | - | $49.85 | $5.70 | 8.7x | -75% |
| FY2010 Q3 | Jun 30 2010 | $37.28 | $5.03 | 7.4x | -79% |
| FY2010 Q2 | Mar 31 2010 | $46.54 | $4.69 | 9.9x | -72% |
| FY2010 Q1 | - | $45.44 | $4.74 | 9.6x | -73% |
| FY2009 Q4 | Sep 30 2009 | $49.19 | $4.84 | 10.2x | -71% |
| FY2009 Q3 | - | $38.74 | $6.01 | 6.4x | -82% |
| FY2009 Q2 | - | $36.85 | $6.01 | 6.1x | -83% |
| FY2009 Q1 | Dec 31 2008 | $40.15 | $5.74 | 7.0x | -80% |
| FY2008 Q4 | - | $59.73 | $5.60 | 10.7x | -70% |
| FY2008 Q3 | Jun 30 2008 | $54.20 | $5.12 | 10.6x | -70% |
| FY2008 Q2 | Mar 31 2008 | $67.09 | $5.05 | 13.3x | -62% |
| FY2008 Q1 | Dec 31 2007 | $83.15 | $5.16 | 16.1x | -54% |
| FY2007 Q4 | Sep 30 2007 | $82.20 | $5.50 | 14.9x | -58% |
| FY2007 Q3 | Jun 30 2007 | $73.86 | $4.97 | 14.9x | -58% |
| FY2007 Q2 | Mar 31 2007 | $63.28 | $4.74 | 13.4x | -62% |
| FY2007 Q1 | Dec 31 2006 | $52.64 | $4.38 | 12.0x | -66% |
| FY2006 Q4 | Sep 30 2006 | $53.38 | $4.07 | 13.1x | -63% |
| FY2006 Q3 | Jun 30 2006 | $43.43 | $4.19 | 10.4x | -71% |
| FY2006 Q2 | Mar 31 2006 | $39.30 | $4.07 | 9.7x | -73% |
| FY2006 Q1 | Dec 31 2005 | $36.92 | $4.05 | 9.1x | -74% |
| FY2005 Q4 | Sep 30 2005 | $42.05 | $3.88 | 10.8x | -69% |
| FY2005 Q3 | - | $46.10 | $3.90 | 11.8x | -67% |
| FY2005 Q2 | - | $44.34 | $3.65 | 12.1x | -66% |
| FY2005 Q1 | Dec 31 2004 | $36.85 | $3.52 | 10.5x | -70% |
| FY2004 Q4 | - | $34.19 | $3.24 | 10.6x | -70% |
| FY2004 Q3 | Jun 30 2004 | $33.37 | $2.80 | 11.9x | -66% |
| FY2004 Q2 | Mar 31 2004 | $34.62 | $2.54 | 13.6x | -61% |
| FY2004 Q1 | Dec 31 2003 | $27.85 | $2.28 | 12.2x | -65% |
| FY2003 Q4 | - | $27.27 | $1.91 | 14.3x | -60% |
| FY2003 Q3 | Jun 30 2003 | $23.28 | $2.16 | 10.8x | -69% |
| FY2003 Q2 | Mar 31 2003 | $18.90 | $2.39 | 7.9x | -78% |
| FY2003 Q1 | - | $20.69 | $2.23 | 9.3x | -74% |
| FY2002 Q4 | Sep 30 2002 | $22.54 | $2.04 | 11.0x | -69% |
| FY2002 Q3 | Jun 30 2002 | $20.33 | $0.15 | 135.5x | +284% |
| FY2001 Q3 | Jun 30 2001 | $17.02 | $1.18 | 14.4x | -59% |
| FY2001 Q2 | Mar 31 2001 | $18.54 | $1.25 | 14.8x | -58% |
| FY2001 Q1 | Dec 31 2000 | $15.85 | $1.37 | 11.6x | -67% |
| FY2000 Q4 | Sep 30 2000 | $18.17 | $1.87 | 9.7x | -72% |
| FY2000 Q3 | Jun 30 2000 | $13.53 | $2.09 | 6.5x | -82% |
Average P/E for displayed period: 35.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
EPC — Frequently Asked Questions
Quick answers to the most common questions about buying EPC stock.
What is EPC's P/E ratio?
Edgewell Personal Care Company (EPC) trailing twelve-month P/E ratio is 43.6x, based on TTM diluted EPS of $-1.67. The 5-year average P/E is 21.5x and the historical range spans 16.1x to 40.2x.
Is EPC stock overvalued or undervalued?
EPC trades at 43.6x P/E, above its 5-year average of 21.5x. The 100th percentile ranking within the 16.1x–40.2x historical range indicates a premium to historical valuation.
Is EPC stock expensive?
Yes, EPC is expensive relative to its own history. The current P/E of 43.6x is above the 5-year average of 21.5x and also above the Consumer Defensive sector median of 18.8x. The stock sits at the 100th percentile of its 5-year valuation range.
What is EPC's historical P/E range?
Over the past 5 years, EPC's P/E ratio has ranged from 16.1x to 40.2x, with a median of 18.4x and an average of 21.5x. The current P/E of 43.6x places the stock at the 100th percentile of this range. Full historical data spans 2000–2025.
How does EPC's P/E compare to the S&P 500?
EPC trades at 43.6x P/E versus the S&P 500 median of 24.4x. The 79% premium to the market typically reflects higher expected earnings growth or quality.
How does EPC's valuation compare to Consumer Defensive peers?
Edgewell Personal Care Company P/E of 43.6x compares to the Consumer Defensive sector median of 18.8x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is EPC's PEG ratio?
EPC PEG ratio is N/A, based on a P/E of 43.6x and EPS growth of -73.1%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is EPC's earnings yield?
EPC earnings yield is 2.29%, the inverse of its 43.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.